etorphine has been researched along with Opioid-Related Disorders in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (39.13) | 18.7374 |
| 1990's | 10 (43.48) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chi, ZQ; Liu, JG; Sun, JF; Tao, YM; Wang, YH; Xu, XJ | 1 |
| Dong, HJ; Gong, ZH; Li, YL; Wen, Q; Yan, LD; Yu, G | 1 |
| Morimoto, Y; Ohmori, S | 1 |
| Chen, XJ; Chi, ZQ; He, Y; Jin, WQ; Liu, ZH; Shen, QX; Zhang, HP | 1 |
| Katz, JL; Medzihradsky, F; Smith, CB; Winger, GD; Woods, JH | 1 |
| Greenspan, DL; Musacchio, JM | 1 |
| Clouet, DH; Yonehara, N | 1 |
| Huang, M; Qin, BY | 1 |
| Herz, A; Schulz, R; Wüster, M | 1 |
| Aceto, MD; Balster, RL; Gmerek, D; Harris, LS; May, EL; Medzihradsky, F; Slifer, BL; Smith, CB; Winger, GD; Woods, JH | 1 |
| Busse, LW; Fujimoto, JM; Lange, DG; Roerig, SC | 1 |
| Miao, H; Qin, BY | 1 |
| Kaneto, H; Nakamura, F; Takahashi, M; Tokuyama, S | 1 |
| Crain, SM; Shen, KF | 2 |
| Feng, J; Hu, X; Liu, F; Luo, Y | 1 |
| Cai, Z; Chen, J; Ha, Y; Ren, Y; Wang, G; Wang, W; Xie, L; Zhang, K; Zheng, J | 1 |
| Bai, HQ; Li, N; Li, Y; Wu, WR; Zhang, KR; Zheng, JW | 1 |
| Chu, P; Chuang, HH; Jan, LY; von Zastrow, M; Whistler, JL | 1 |
| Gong, ZH; Liu, JG; Qin, BY | 2 |
| Fly, CL; Medzihradsky, F; Smith, CB; Swain, HH; Woods, JH | 1 |
| Luini, A; Manara, L; Tavani, A | 1 |
3 review(s) available for etorphine and Opioid-Related Disorders
| Article | Year |
|---|---|
Dihydroetorphine: a potent analgesic: pharmacology, toxicology, pharmacokinetics, and clinical effects.
Topics: Administration, Cutaneous; Analgesics, Opioid; Animals; Clinical Trials as Topic; Drug Tolerance; Etorphine; Humans; In Vitro Techniques; Opioid-Related Disorders; Pain, Intractable; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2002 |
Biochemical reactions between opiate receptor binding and inhibition of neurotransmission.
Topics: Adenylyl Cyclases; Animals; Brain Chemistry; Calcium; Calmodulin; Etorphine; Humans; Methadone; Molecular Weight; Morphine; Narcotics; Nerve Endings; Nerve Tissue Proteins; Opioid-Related Disorders; Phosphodiesterase Inhibitors; Phosphorylation; Protein Binding; Protein Kinases; Receptors, Opioid; Synaptic Transmission | 1984 |
Etorphine elicits unique inhibitory-agonist and excitatory-antagonist actions at opioid receptors on sensory neurons: new rationale for improved clinical analgesia and treatment of opiate addiction.
Topics: Animals; Etorphine; Excitatory Amino Acid Antagonists; Narcotic Antagonists; Neurons, Afferent; Opioid-Related Disorders; Pain; Receptors, Opioid | 1995 |
20 other study(ies) available for etorphine and Opioid-Related Disorders
| Article | Year |
|---|---|
Paradoxical relationship between RAVE (relative activity versus endocytosis) values of several opioid receptor agonists and their liability to cause dependence.
Topics: Analgesics, Opioid; Animals; Cell Membrane; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Endocytosis; Etorphine; Fentanyl; Guanosine 5'-O-(3-Thiotriphosphate); Morphine; Opioid-Related Disorders; Receptors, Opioid, mu | 2010 |
TH-030418: a potent long-acting opioid analgesic with low dependence liability.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Cell Culture Techniques; CHO Cells; Conditioning, Classical; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Etorphine; Female; Injections, Subcutaneous; Ligands; Male; Mice; Mice, Inbred Strains; Molecular Structure; Nociceptin Receptor; Opioid-Related Disorders; Pain; Protein Binding; Radioligand Assay; Receptors, Opioid; Time Factors; Transfection | 2011 |
Binding affinity to and dependence on some opioids in Sf9 insect cells expressing human mu-opioid receptor.
Topics: Analgesics, Opioid; Animals; Baculoviridae; Binding, Competitive; Cells, Cultured; Cyclic AMP; Etorphine; Female; Fentanyl; Heroin; Male; Mice; Opioid-Related Disorders; Receptors, Opioid, mu; Spodoptera; Transfection | 2003 |
Evaluation of new compounds for opioid activity (1983).
Topics: Animals; Binding, Competitive; Drug Evaluation; Etorphine; Guinea Pigs; Humans; Macaca mulatta; Mice; Muscle Contraction; Muscle, Smooth; Narcotic Antagonists; Narcotics; Nociceptors; Opioid-Related Disorders; Receptors, Opioid; Substance Withdrawal Syndrome | 1984 |
The effect of tolerance on opiate dependence as measured by the adenylate cyclase rebound response to naloxone in the NG108-15 model system.
Topics: Adenylyl Cyclases; Animals; Drug Tolerance; Etorphine; Humans; Hybrid Cells; Morphine; Naloxone; Opioid-Related Disorders; Receptors, Opioid | 1984 |
[Physical dependence of dihydroetorphine in mice and monkeys (author's transl)].
Topics: Analgesics; Animals; Etorphine; Female; Humans; Macaca mulatta; Male; Mice; Morphinans; Morphine Dependence; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1982 |
Inquiry into endorphinergic feedback mechanisms during the development of opiate tolerance/dependence.
Topics: Animals; Brain; Dextrorphan; Drug Tolerance; Endorphins; Etorphine; Feedback; Humans; Levorphanol; Loperamide; Male; Naloxone; Opioid-Related Disorders; Pituitary Gland; Rats; Receptors, Opioid | 1980 |
Evaluation of new compounds for opioid activity in rhesus monkey, rat, and mouse (1984)
Topics: Animals; Binding, Competitive; Chemical Phenomena; Chemistry; Etorphine; Injections, Intravenous; Macaca mulatta; Male; Mice; Morphine; Muscle, Smooth; Narcotics; Opioid-Related Disorders; Rats; Rats, Inbred Strains; Self Administration; Stereoisomerism | 1984 |
Withdrawal tolerance and unidirectional non-cross-tolerance in narcotic pellet-implanted mice.
Topics: Animals; Dose-Response Relationship, Drug; Drug Implants; Drug Tolerance; Etorphine; Heroin; Humans; Male; Methadone; Mice; Morphine; Narcotics; Opioid-Related Disorders; Solubility; Substance Withdrawal Syndrome | 1983 |
Influences of locus coeruleus lesions and reserpine treatment on opioid physical dependence in rats.
Topics: Animals; Body Weight; Etorphine; Female; Locus Coeruleus; Male; Morphine Dependence; Neurons; Opioid-Related Disorders; Rats; Rats, Wistar; Reserpine; Substance Withdrawal Syndrome | 1995 |
Physical dependence produced by dihydroetorphine in mice.
Topics: Analgesics; Animals; Etorphine; Injections, Intraventricular; Male; Mice; Mice, Inbred Strains; Morphine Dependence; Naloxone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1994 |
Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence.
Topics: Analgesics; Animals; Cells, Cultured; Diprenorphine; Drug Tolerance; Electrophysiology; Enkephalin, Leucine-2-Alanine; Etorphine; Ganglia, Spinal; Mice; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Neurons, Afferent; Opioid-Related Disorders | 1994 |
Determination of dihydroetorphine in biological fluids by gas chromatography-mass spectrometry using selected-ion monitoring.
Topics: Analgesics, Opioid; Calibration; Etorphine; Gas Chromatography-Mass Spectrometry; Humans; Hydrogen-Ion Concentration; Opioid-Related Disorders; Reference Standards; Reproducibility of Results; Solvents | 1996 |
Psychic dependent potential of dihydroetorphine.
Topics: Analgesics, Opioid; Animals; Etorphine; Haplorhini; Mice; Opioid-Related Disorders; Rats | 1998 |
Immunosuppressive effects of dihydroetorphine, a potent narcotic analgesic, in dihydroetorphine-dependent mice.
Topics: Analgesics, Opioid; Animals; Antibody-Producing Cells; Body Weight; Cell Division; Dose-Response Relationship, Drug; Etorphine; Female; Hypersensitivity, Delayed; Immunosuppressive Agents; Lymphocyte Count; Lymphocyte Subsets; Lymphocytes; Lymphokines; Mice; Mice, Inbred C57BL; Naloxone; Opioid-Related Disorders; Organ Size; Spleen; Substance Withdrawal Syndrome; Thymus Gland | 1999 |
Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction.
Topics: Arrestin; Cell Line; Drug Tolerance; Electrophysiology; Endocytosis; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Etorphine; Flow Cytometry; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Guanine Nucleotides; Humans; Immunohistochemistry; Ligands; Morphine; Narcotics; Opioid-Related Disorders; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Muscarinic; Receptors, Opioid, mu; Signal Transduction | 1999 |
Effects of opioid receptor agonists on cAMP second messenger system.
Topics: Adenylyl Cyclases; Analgesics, Opioid; Buprenorphine; Cyclic AMP; Etorphine; Glioma; Humans; Hybrid Cells; Methadone; Morphine; Neuroblastoma; Opioid-Related Disorders; Receptors, Opioid; Receptors, Opioid, delta; Tumor Cells, Cultured | 1999 |
Effects of low-pH treatment on cAMP second messenger system regulated by different opioid agonists.
Topics: Adenylyl Cyclases; Analgesics, Opioid; Buprenorphine; Cyclic AMP; Etorphine; Glioma; Humans; Hybrid Cells; Hydrogen-Ion Concentration; Methadone; Morphine; Neuroblastoma; Opioid-Related Disorders; Receptors, Opioid, delta; Tumor Cells, Cultured | 1999 |
Annual report: evaluation of new compounds for opioid activity (1979).
Topics: Animals; Drug Evaluation, Preclinical; Etorphine; Guinea Pigs; Haplorhini; Humans; Macaca mulatta; Mice; Narcotics; Opioid-Related Disorders; Receptors, Opioid; Self Administration | 1979 |
Time course of etorphine levels in tissues of opiate tolerant and nontolerant rats.
Topics: Analgesics; Animals; Brain; Drug Tolerance; Etorphine; Humans; Male; Morphinans; Morphine Dependence; Opioid-Related Disorders; Rats; Sulfobromophthalein; Time Factors; Tissue Distribution | 1979 |